GLP-1–based medications are increasingly used to treat obesity and type 2 diabetes. They help regulate appetite, promote weight loss, and improve blood sugar control. These medications include semaglutide, which acts on GLP-1 receptors, and tirzepatide, which acts on both GLP-1 and GIP receptors.

Despite these benefits, some people stop taking them for various reasons, including cost, insurance changes, medication shortages, side effects, or personal preference. Others may choose to stop after reaching their health or weight-related goals.

But what happens to the body when these medications are discontinued? Nebraska Medicine nurse practitioner Erin Williams, MSN, APRN, FNP-C and endocrinologist Brianna Johnson-Rabbett, MD, DABOM, answer common questions about stopping GLP-1–based medications.

Are GLP-1–based medications meant to be taken long term?

For many people, yes. Obesity and type 2 diabetes are chronic diseases, and GLP-1-based medications are often used long term to help maintain their health benefits. 

Can someone stop taking a GLP-1 suddenly, or should the dose be tapered?

GLP-1–based medications generally don't require a gradual dose reduction, or taper, to prevent withdrawal symptoms. However, your doctor or health care provider may recommend gradually reducing your dose depending on your goals and circumstances.

As the medication leaves your body, you may experience changes in appetite, blood sugar levels and weight. Talk with your health care provider before stopping treatment, especially if you have type 2 diabetes, because you may need adjustments to your blood sugar management plan.

What happens to the body after stopping a GLP-1?

As the medication's effects wear off, some people may notice:

• Increased hunger
• Feeling less full after meals or thinking about food more frequently
• Higher blood sugar levels, particularly for people with type 2 diabetes
• Diminishing improvements in blood pressure, cholesterol, and metabolic health

Is it common to regain weight after stopping a GLP-1?

Yes. Studies show that most people experience weight recurrence after stopping GLP-1–based medications, although the amount varies from person to person. 

For example, in the STEP 1 extension study, participants who discontinued semaglutide regained an average of approximately two-thirds of the weight they had lost within one year. Researchers reported similar findings with tirzepatide in the SURMOUNT-4 trial.

However, weight recurrence should not be viewed as a personal failure. These findings reinforce that ongoing treatment is often necessary to maintain the benefits achieved with medication.

Is it possible to stop a GLP-1 medication without regaining weight?

Some people maintain some of their weight loss after stopping GLP-1–based medications. However, most people experience weight recurrence, making it difficult to maintain all or most of the weight lost. This is due in part to biological factors influencing hunger and weight regulation.

How can people maintain their results after stopping a GLP-1?

Regular physical activity, strength training, adequate protein intake, balanced nutrition, healthy sleep habits, and ongoing medical follow-up can help support long-term health goals. However, these efforts may not prevent weight recurrence after stopping treatment. Regaining weight after stopping a GLP-1–based medication is not a failure of willpower.

Can someone restart a GLP-1–based medication after stopping?

In many cases, yes. Whether restarting treatment is appropriate depends on the medication, how long you've been off it, your health status, and any previous side effects.

After a prolonged break, your doctor or health care provider may recommend restarting at a lower dose to help minimize gastrointestinal side effects, such as nausea, vomiting and diarrhea, as your body readjusts to the medication. Always consult your health care provider for individualized dosing guidance before restarting treatment.

Does stopping a GLP-1 affect people with obesity and type 2 diabetes differently?

Yes. People taking GLP-1–based medications for obesity may experience increased hunger, weight regain, or worsening obesity-related health conditions. Individuals taking GLP-1–based medications for type 2 diabetes may experience increased blood sugar levels, making ongoing medical supervision especially important.

What should people know before starting or stopping GLP-1-based medications?

GLP-1–based medications can be highly effective treatments for obesity and type 2 diabetes, but they're often long-term tools rather than short-term solutions. Both conditions require ongoing management, and treatment success goes beyond weight loss or blood sugar numbers alone. The goal is to improve long-term health and quality of life with a treatment plan that's sustainable for you.

If you're considering starting or stopping a GLP-1–based medication, talk with your doctor or health care provider about your goals, concerns, and available alternatives.

FAQ

Do you have to stay on GLP-1–based medications forever?

GLP-1–based medications are generally meant to be a long-term therapy because obesity and type 2 diabetes are chronic conditions. However, treatment may need to be discontinued if the medication isn't well tolerated, contraindications arise, or other barriers prevent continued use.

Is it bad to suddenly stop taking GLP-1–based medications?

GLP-1–based medications generally don't require tapering to prevent withdrawal symptoms. However, stopping can lead to increased hunger, weight recurrence, or rising blood sugar levels. Talk with your health care provider before stopping treatment, especially if you have type 2 diabetes, because you may need to adjust your blood sugar management plan.

Can you stop taking semaglutide and keep the weight off?

Some people may maintain a portion of their weight loss, but most people taking semaglutide for weight loss experience weight recurrence after stopping the medication. Semaglutide is intended for long-term treatment of obesity or type 2 diabetes.